IRIS Accounts Production v23.3.1.45 13471461 director 1.7.22 30.6.23 30.6.23 0 0 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh134714612022-06-30134714612023-06-30134714612022-07-012023-06-30134714612021-06-21134714612021-06-222022-06-30134714612022-06-3013471461ns10:Originalns15:EnglandWales2022-07-012023-06-3013471461ns14:PoundSterlingns10:Original2022-07-012023-06-3013471461ns10:Originalns10:Director12022-07-012023-06-3013471461ns10:Original2022-07-012023-06-3013471461ns10:Original2023-06-3013471461ns10:Originalns10:PrivateLimitedCompanyLtd2022-07-012023-06-3013471461ns10:Originalns10:SmallEntities2022-07-012023-06-3013471461ns10:Originalns10:AuditExemptWithAccountantsReport2022-07-012023-06-3013471461ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3013471461ns10:SmallCompaniesRegimeForAccountsns10:Original2022-07-012023-06-3013471461ns10:Originalns10:FullAccounts2022-07-012023-06-3013471461ns10:Original2021-06-222022-06-3013471461ns10:Original12022-07-012023-06-3013471461ns10:Originalns10:OrdinaryShareClass12022-07-012023-06-3013471461ns10:Originalns10:RegisteredOffice2022-07-012023-06-3013471461ns10:Original2022-06-3013471461ns10:Originalns5:CurrentFinancialInstruments2023-06-3013471461ns10:Originalns5:CurrentFinancialInstruments2022-06-3013471461ns5:ShareCapitalns10:Original2023-06-3013471461ns5:ShareCapitalns10:Original2022-06-3013471461ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-06-3013471461ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-3013471461ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-07-012023-06-3013471461ns10:Originalns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-07-012023-06-3013471461ns5:IntangibleAssetsOtherThanGoodwillns10:Original2023-06-3013471461ns10:Originalns10:OrdinaryShareClass12023-06-3013471461ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-3013471461ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-07-012023-06-30
REGISTERED NUMBER: 13471461 (England and Wales)







Unaudited Financial Statements for the Year Ended 30 June 2023

for

ChangeMed Ltd

ChangeMed Ltd (Registered number: 13471461)






Contents of the Financial Statements
for the Year Ended 30 June 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 5

ChangeMed Ltd

Company Information
for the Year Ended 30 June 2023







DIRECTOR: Mrs J Flynn





REGISTERED OFFICE: Canal Cottage
Leek Road
Sutton Macclesfield
Cheshire
SK11 0JF





REGISTERED NUMBER: 13471461 (England and Wales)





ACCOUNTANTS: Dunkley's
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
BS32 4JY

ChangeMed Ltd (Registered number: 13471461)

Balance Sheet
30 June 2023

30.6.23 30.6.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 6,892 -

CURRENT ASSETS
Debtors 5 101 -
Cash at bank 6,433 5,765
6,534 5,765
CREDITORS
Amounts falling due within one year 6 4,109 3,943
NET CURRENT ASSETS 2,425 1,822
TOTAL ASSETS LESS CURRENT LIABILITIES 9,317 1,822

CAPITAL AND RESERVES
Called up share capital 7 2 2
Retained earnings 8 9,315 1,820
SHAREHOLDERS' FUNDS 9,317 1,822

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 February 2024 and were signed by:





Mrs J Flynn - Director


ChangeMed Ltd (Registered number: 13471461)

Notes to the Financial Statements
for the Year Ended 30 June 2023

1. STATUTORY INFORMATION

ChangeMed Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of fifteen years.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

ChangeMed Ltd (Registered number: 13471461)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
Additions 6,950
At 30 June 2023 6,950
AMORTISATION
Charge for year 58
At 30 June 2023 58
NET BOOK VALUE
At 30 June 2023 6,892

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.23 30.6.22
£    £   
Amounts owed by group undertakings 101 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.23 30.6.22
£    £   
Tax 161 427
Directors' current accounts 628 316
Deferred income 2,000 2,000
Accrued expenses 1,320 1,200
4,109 3,943

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.23 30.6.22
value: £    £   
2 Ordinary £1 2 2

8. RESERVES
Retained
earnings
£   

At 1 July 2022 1,820
Profit for the year 7,495
At 30 June 2023 9,315

9. RELATED PARTY DISCLOSURES

The balance on the intercompany owed by ChangeMed Ltd was £101 (2022: £NIL ).

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
ChangeMed Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of ChangeMed Ltd for the year ended 30 June 2023 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of ChangeMed Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of ChangeMed Ltd and state those matters that we have agreed to state to the director of ChangeMed Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ChangeMed Ltd and its director for our work or for this report.

It is your duty to ensure that ChangeMed Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of ChangeMed Ltd. You consider that ChangeMed Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of ChangeMed Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Dunkley's
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
BS32 4JY


29 February 2024